BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38519890)

  • 21. The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma.
    Qi C; Zhou Y; Hu Z; Niu H; Yue F; An H; Chen Z; Wang P; Wang L; Duan G
    J Int Med Res; 2022 Jun; 50(6):3000605221109382. PubMed ID: 35770522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.
    Cangelosi D; Blengio F; Versteeg R; Eggert A; Garaventa A; Gambini C; Conte M; Eva A; Muselli M; Varesio L
    BMC Bioinformatics; 2013; 14 Suppl 7(Suppl 7):S12. PubMed ID: 23815266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ganglioside G
    Balis FM; Busch CM; Desai AV; Hibbitts E; Naranjo A; Bagatell R; Irwin M; Fox E
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28031. PubMed ID: 31612589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical features of neuroblastoma: an analysis of 44 children].
    Zhu CG; He XL; Tang ZG; Chen KK; Zou RY; Tian X; You YL
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1193-1197. PubMed ID: 33172554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma.
    Song J; Zhao Q; Xu Y; Zhu L
    Int Immunopharmacol; 2020 Nov; 88():106994. PubMed ID: 33182060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
    Naranjo A; Irwin MS; Hogarty MD; Cohn SL; Park JR; London WB
    JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and significance of programmed cell death ligand-1 in neuroblastoma tissues].
    Liao R; Sun XF; Zhen ZZ; Huang DS
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):735-740. PubMed ID: 30293276
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
    Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
    Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma.
    Song J; Song L; Lv Z; Liu J; Feng X; Zhang S; Song A
    Int J Genomics; 2022; 2022():2417351. PubMed ID: 35535346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients.
    Wang J; Meng X; Chen K; Feng J
    Front Oncol; 2022; 12():1014845. PubMed ID: 36530992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comprehensive analysis of potential prognostic biomarkers for MYCN-amplified neuroblastoma].
    Fan X; Lu HT; Hou L; Zhang L; Yang BY; Chen WM; Zhang HY; Chen X; Li FJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):262-268. PubMed ID: 32204764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors of Recurrence After Complete Response in Children with Neuroblastoma: A 16-Year Retrospective Study of 179 Cases.
    Li F; Zhang W; Hu H; Zhang Y; Li J; Huang D
    Cancer Manag Res; 2022; 14():107-122. PubMed ID: 35023974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
    Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
    BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma.
    Su Y; Wang L; Wang X; Yue Z; Xing T; Zhao W; Zhao Q; Duan C; Huang C; Han Y; Qiu L; Cheng X; Liu Y; Ma X
    Cancer Med; 2019 Apr; 8(4):1558-1566. PubMed ID: 30793512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.
    Pinto N; Naranjo A; Ding X; Zhang FF; Hibbitts E; Kennedy R; Tibbetts R; Wong-Michalak S; Craig DW; Manojlovic Z; Hogarty MD; Kreissman S; Bagatell R; Irwin MS; Park JR; Asgharzadeh S
    Clin Cancer Res; 2023 Apr; 29(8):1546-1556. PubMed ID: 36749880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and prognostic analyses of cervical neuroblastoma].
    Liu QY; Wang SC; Jin YQ; Chu P; Guo YL; Ma XL; Su Y; Zhang J; Li YZ; Zhang XX; Sun N; Liu ZY; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):711-717. PubMed ID: 35725314
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroblastoma in adolescents: genetic and clinical characterisation.
    Castel V; Villamón E; Cañete A; Navarro S; Ruiz A; Melero C; Herrero A; Yáñez Y; Noguera R
    Clin Transl Oncol; 2010 Jan; 12(1):49-54. PubMed ID: 20080471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
    Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
    J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.